Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

Polaris AI Pharma Corp. (041910.KQ)

Compare
5,580.00
0.00
(0.00%)
At close: April 4 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
59,602,371.96
59,602,371.96
64,214,830.71
62,036,332.95
60,400,509.53
Cost of Revenue
48,328,411.39
48,328,411.39
49,917,940.65
49,371,537.05
46,574,550.69
Gross Profit
11,273,960.57
11,273,960.57
14,296,890.06
12,664,795.90
13,825,958.84
Operating Expense
11,098,002
11,098,002
8,953,083
9,503,057
9,620,582
Operating Income
175,958.57
175,958.57
5,343,807.06
3,161,738.90
4,205,376.84
Net Non Operating Interest Income Expense
1,175,048.30
1,175,048.30
698,348.36
569,215.93
322,332.87
Pretax Income
4,207,973.95
4,207,973.95
4,474,817.59
-8,415,479.81
7,773,022.21
Tax Provision
260,111.94
260,111.94
651,174.89
-2,051,626.51
898,209.47
Net Income Common Stockholders
3,947,862.01
3,947,862.01
3,823,642.69
-6,363,853.29
6,874,813
Basic EPS
320.00
--
327.00
-545.00
589.00
Diluted EPS
320.00
--
327.00
-545.00
589.00
Basic Average Shares
12,337.07
--
11,693.10
11,676.80
11,680.01
Diluted Average Shares
12,337.07
--
11,693.10
11,676.80
11,680.01
Total Operating Income as Reported
175,958.62
175,958.62
5,343,807.01
3,161,738.70
4,205,376.90
Rent Expense Supplemental
--
--
--
--
24,432
Total Expenses
59,426,413.39
59,426,413.39
58,871,023.65
58,874,594.05
56,195,132.69
Net Income from Continuing & Discontinued Operation
3,947,862.01
3,947,862.01
3,823,642.69
-6,363,853.29
6,874,813
Normalized Income
2,951,426.92
2,951,426.92
5,982,621.74
-5,965,079.85
7,096,030.45
Interest Income
1,197,576
1,197,576
736,633
598,855
328,612
Interest Expense
22,527
22,527
38,284
29,640
6,279
Net Interest Income
1,175,048.30
1,175,048.30
698,348.36
569,215.93
322,332.87
EBIT
4,230,500.95
4,230,500.95
4,513,101.59
-8,385,839.81
7,779,301.21
EBITDA
6,604,044.95
6,604,044.95
6,828,546.59
-5,844,726.81
10,453,332.21
Reconciled Cost of Revenue
48,328,411.39
48,328,411.39
49,917,940.65
49,371,537.05
46,574,550.69
Reconciled Depreciation
2,373,544
2,373,544
2,315,445
2,541,113
2,674,031
Net Income from Continuing Operation Net Minority Interest
3,947,862.01
3,947,862.01
3,823,642.69
-6,363,853.29
6,874,813
Total Unusual Items Excluding Goodwill
1,062,087
1,062,087
-2,526,658
-527,333
-250,120
Total Unusual Items
1,062,087
1,062,087
-2,526,658
-527,333
-250,120
Normalized EBITDA
5,541,957.95
5,541,957.95
9,355,204.59
-5,317,393.81
10,703,452.21
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
65,651.91
65,651.91
-367,678.95
-128,559.56
-28,902.55
12/31/2021 - 2/6/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade